Bladder Cancer Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working

Urine is stored in the bladder, which is a hollow organ in the lower abdomen. Bladder cancer develops in the bladder's lining. Transitional cell carcinoma, commonly known as urothelial carcinoma, is the most frequent type of bladder cancer. Smoking is one of the leading causes of bladder cancer. Bladder cancer is frequently detected in its early stages.

Bladder cancer was rated 10th among all cancers in the globe, with 549,000 new cases and 200,000 deaths each year; it contributed 3.4 percent to the overall cancer burden worldwide. There were 18,921 new cases and 10,231 deaths in India.

DelveInsight’s Bladder Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Bladder Cancer, historical and forecasted epidemiology as well as the Bladder Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

Some of the key facts of the Bladder Cancer Market Report:

  •  An Estimated 573,278 people were diagnosed with Bladder Cancer WorldWide in 2020

  •  Bladder Cancer is the fourth most common cancer among the men

  • There has been a decline of 1%/year in the number of cases of Bladder Cancer in the US from 2009-to 2018 

  • Bladder cancer was rated 10th among all cancers in the globe, with 549,000 new cases and 200,000 deaths each year 

  • While the specific aetiology of bladder cancer is unknown, it has been related to a number of risk factors, including tobacco use and exposure to certain chemicals and gases. In addition, persons who have a family history of bladder cancer are more likely to get the disease

Got queries? Click here to know more about the Bladder Cancer Market Landscape

Bladder Cancer Symptoms: 

  • Blood in the Urine can be seen

  • Pain is felt while urinating

  • Back Pain

  • Pain in The Pelvic area

Bladder Cancer Market: 

The dynamics of the Bladder Cancer market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as and others during the forecasted period 2018-2030. 

The key players working in the field of Bladder Cancer are the - Swiss Group for Clinical Cancer Research, University of Kansas Medical Center, University of Oklahoma, Radiation Therapy Oncology Group, National Cancer Institute (NCI), and ImmunityBio, Inc. 

Learn more by requesting for sample @ Bladder Cancer Market Landscape 

Bladder Cancer Pipeline Therapies:

  •  VPM1002BC

  • Ascorbic Acid

  • Avelumab

  • Cisplatin

  •  Paclitaxel

  • Mitomycin C

  • N-803 and BCG 

Bladder Cancer and Key Companies: 

  • Swiss Group for Clinical Cancer Research

  • University of Kansas Medical Center

  • University of Oklahoma

  • Radiation Therapy Oncology Group

  • National Cancer Institute (NCI)

  • ImmunityBio, Inc. 

Click here to read more about Bladder Cancer Market Outlook 2032

Related Reports: 

Bladder Cancer Pipeline 

 "Bladder Cancer Pipeline Insight, 2021" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Bladder Cancer market. A detailed picture of the Bladder Cancer pipeline landscape is provided, which includes the disease overview and Bladder Cancer treatment guidelines. 

Bladder Cancer Epidemiology 

DelveInsight's 'Bladder Cancer  Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Bladder Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports By Delveinsight:

Comments

Popular posts from this blog

Understanding the Selectivity of CELMoDs in Targeting Cancer Cells

The Evolution of Dietary Supplements: Trends and Growth Patterns

In-depth Analysis: Orthopedic Trauma Device Market Dynamics